| 浅表性膀胱肿瘤术后联合药物膀胱灌注的治疗进展 |
| |
| 引用本文： | 章宗武,梁朝朝.浅表性膀胱肿瘤术后联合药物膀胱灌注的治疗进展[J].安徽医药,2006,10(1):6-8. |
| |
| 作者姓名： | 章宗武 梁朝朝 |
| |
| 作者单位： | 1. 安徽医科大学第一附属医院泌尿外科;安徽医学高等专科学校附属医院泌尿外科,安徽,合肥,230022
2. 安徽医科大学第一附属医院泌尿外科 |
| |
| 摘 要： | 术后膀胱灌注药物可以提高浅表性膀胱肿瘤(STCC)治疗的效果,联合用药对降低肿瘤的复发率,减少其毒副作用效果明显优于单用药物。本文就浅表性膀胱肿瘤术后联合药物灌注的进展进行综述。
|
| 关 键 词： | 膀胱肿瘤 灌注 肿瘤复发 药物 |
| 收稿时间： | 07 14 2005 12:00AM |
| 修稿时间： | 2005年7月14日 |
The development of intravesical instillation by drug in combined treatment for primary superficial bladder cancer following operation |
| |
| ZHANG Zong-wu,LIANG Zhao-zhao.The development of intravesical instillation by drug in combined treatment for primary superficial bladder cancer following operation[J].Anhui Medical and Pharmaceutical Journal,2006,10(1):6-8. |
| |
| Authors: | ZHANG Zong-wu LIANG Zhao-zhao |
| |
| Institution: | 1. Department of Urology, Frist Affiliated Hospital of Anhui Medical University; 2. Department of Urology,Affiliated Hospital of Anhui Medical college, Hefei 230022, China |
| |
| Abstract: | Intravesical chemotherapy after operation may improve the therapeutic effects of primary superficial bladder cancer(STCC),the effects of drug in combined treatment were greater than that alone to reduce primary superficial bladder cancer recurrence and side effect.This development of intravesical instillation by drug in combined treatment for primary superficial bladder cancer following operation will be summed up as follows. |
| |
| Keywords: | bladder neoplasms perfusion neoplasm recurrence drug |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
